Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 2012

View Archived Issues

Researchers at Lycera prepare new F1F0 ATPase inhibitors

Bristol-Myers Squibb patents new agents for HIV infection

Japanese team discloses novel treatments for diabetes

New EFNA modulators designed by Stem CentRx

New fusion protein from Bristol-Myers Squibb demonstrates antidiabetic activity

Bracco designs novel vaccines for allergy

New D3/5-HT2A receptor modulators patented by Roche

Belgian group discloses novel treatments for neurodegenerative disorders

NPS-1034 shows promise in EGFR-mutant cancer models

Grifols invests in biotechnology firm

CHF-5074 is well tolerated in patients with mild cognitive impairment

GlobeImmune patents novel vaccines for Ad-36 infection and obesity

Alnylam and Ascletis enter collaboration

GlaxoSmithKline withdraws supplemental NDA for Tykerb

Intranasal CP-024 leads to IGF-I induction in healthy volunteers

SEMA7A may have potential as a therapeutic target in breast cancer

Neupro launched in U.S. for Parkinson's disease and RLS

GSK and Theravance file applications for combination COPD candidate

Topline results expected early from phase IIb study of vigabatrin

Tissue Therapies obtains CE Mark for VitroGro ECM wound care product

OncoGenex provides update on phase III development of anticancer candidate

Supernus clarifies tentative approval conditions for Trokendi XR

In vivo results for ARRY-981 presented

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...